1-36097935-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_005202.4(COL8A2):c.1746C>T(p.Thr582Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0034 in 1,610,776 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0030 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0034 ( 9 hom. )
Consequence
COL8A2
NM_005202.4 synonymous
NM_005202.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.404
Genes affected
COL8A2 (HGNC:2216): (collagen type VIII alpha 2 chain) This gene encodes the alpha 2 chain of type VIII collagen. This protein is a major component of the basement membrane of the corneal endothelium and forms homo- or heterotrimers with alpha 1 (VIII) type collagens. Defects in this gene are associated with Fuchs endothelial corneal dystrophy and posterior polymorphous corneal dystrophy type 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 1-36097935-G-A is Benign according to our data. Variant chr1-36097935-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 771113.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.404 with no splicing effect.
BS2
High AC in GnomAd4 at 451 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL8A2 | ENST00000397799.2 | c.1746C>T | p.Thr582Thr | synonymous_variant | 4/4 | 5 | NM_005202.4 | ENSP00000380901.1 | ||
COL8A2 | ENST00000481785.1 | c.1551C>T | p.Thr517Thr | synonymous_variant | 2/2 | 1 | ENSP00000436433.1 | |||
COL8A2 | ENST00000303143.9 | c.1746C>T | p.Thr582Thr | synonymous_variant | 2/2 | 2 | ENSP00000305913.4 |
Frequencies
GnomAD3 genomes AF: 0.00296 AC: 451AN: 152232Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
451
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00320 AC: 786AN: 245496Hom.: 2 AF XY: 0.00313 AC XY: 418AN XY: 133484
GnomAD3 exomes
AF:
AC:
786
AN:
245496
Hom.:
AF XY:
AC XY:
418
AN XY:
133484
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00344 AC: 5021AN: 1458426Hom.: 9 Cov.: 37 AF XY: 0.00336 AC XY: 2439AN XY: 725640
GnomAD4 exome
AF:
AC:
5021
AN:
1458426
Hom.:
Cov.:
37
AF XY:
AC XY:
2439
AN XY:
725640
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00296 AC: 451AN: 152350Hom.: 2 Cov.: 33 AF XY: 0.00332 AC XY: 247AN XY: 74496
GnomAD4 genome
AF:
AC:
451
AN:
152350
Hom.:
Cov.:
33
AF XY:
AC XY:
247
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 30, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | COL8A2: BP4, BP7 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at